Organ responses 12 months after treatment according to 6-month hematologic response
| 6-mo hematologic response . | 12-mo cardiac response (%) . | 12-mo renal response (%) . | 12-mo liver response (%) . |
|---|---|---|---|
| CR | 67/113 (59.3) | 32/148 (21.6) | 9/20 (45) |
| CR, dFLC < 10 mg/L | 43/72 (59.7) | 28/100 (28) | 6/16 (37.5) |
| CR, dFLC ≥ 10 mg/L | 24/41 (58.5) | 4/48 (8.3) | 3/4 (75) |
| VGPR | 55/119 (46.2) | 23/122 (18.9) | 9/21 (42.9) |
| PR | 21/59 (35.6) | 12/78 (15.4) | 6/17 (35.3) |
| Nonresponse | 5/25 (20) | 6/56 (10.7) | 2/7 (28.6) |
| 6-mo hematologic response . | 12-mo cardiac response (%) . | 12-mo renal response (%) . | 12-mo liver response (%) . |
|---|---|---|---|
| CR | 67/113 (59.3) | 32/148 (21.6) | 9/20 (45) |
| CR, dFLC < 10 mg/L | 43/72 (59.7) | 28/100 (28) | 6/16 (37.5) |
| CR, dFLC ≥ 10 mg/L | 24/41 (58.5) | 4/48 (8.3) | 3/4 (75) |
| VGPR | 55/119 (46.2) | 23/122 (18.9) | 9/21 (42.9) |
| PR | 21/59 (35.6) | 12/78 (15.4) | 6/17 (35.3) |
| Nonresponse | 5/25 (20) | 6/56 (10.7) | 2/7 (28.6) |